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The gut is an efficient barrier which protects against the passage of pathogenic
microorganisms and potential harmful macromolecules into the body, in addition to
its primary function of nutrient digestion and absorption. Contrary to the restricted
macromolecular passage in adulthood, enhanced transfer takes place across the
intestines during early life, due to the high endocytic capacity of the immature intestinal
epithelial cells during the fetal and/or neonatal periods. The timing and extent of
this enhanced endocytic capacity is dependent on animal species, with a prominent
non-selective intestinal macromolecular transfer in newborn ungulates, e.g., pigs, during
the first few days of life, and a selective transfer of mainly immunoglobulin G (IgG),
mediated by the FcRn receptor, in suckling rodents, e.g., rats and mice. In primates,
maternal IgG is transferred during fetal life via the placenta, and intestinal macromolecular
transfer is largely restricted in human neonates. The period of intestinal macromolecular
transmission provides passive immune protection through the transfer of IgG antibodies
from an immune competent mother; and may even have extra-immune beneficial
effects on organ maturation in the offspring. Moreover, intestinal transfer during the
fetal/neonatal periods results in increased exposure to microbial and food antigens
which are then presented to the underlying immune system, which is both naïve
and immature. This likely stimulates the maturation of the immune system and shifts
the response toward tolerance induction instead of activation or inflammation, as
usually seen in adulthood. Ingestion of mother’s milk and the dietary transition to
complex food at weaning, as well as the transient changes in the gut microbiota
during the neonatal period, are also involved in the resulting immune response.
Any disturbances in timing and/or balance of these parallel processes, i.e., intestinal
epithelial maturation, luminal microbial colonization and mucosal immune maturation
due to, e.g., preterm birth, infection, antibiotic use or nutrient changes during the
neonatal period, might affect the establishment of the immune system in the infant.
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This review will focus on how differing developmental processes in the intestinal
epithelium affect the macromolecular passage in different species and the possible
impact of such passage on the establishment of immunity during the critical perinatal
period in young mammals.
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INTRODUCTION
The gut, in addition to its primary function of nutrient
digestion and absorption, constitutes an effective barrier to
protect against the invasion of pathogenic microorganisms and
passage of potential harmful macromolecules into the body.
However, as opposed to the restricted macromolecular passage
in the adult, enhanced transfer of macromolecules across the
immature intestinal epithelium takes place during the fetal
and neonatal periods (1). The high intestinal permeability
during these periods is due to the high endocytic capacity
of the immature (fetal-type) enterocytes (2–4). These fetal-
type enterocytes internalize luminal content containing
macromolecules, by fluid-phase or receptor-mediated
endocytosis, either for intracellular digestion in digestive
vacuoles or for their vesicular transfer through the cell and
release on the basolateral side (transcytosis). The intestinal
transfer can either be non-selective, with uptake and passage
of an array of luminal macromolecules, or the transfer can
be more selective due to epithelial expression of the neonatal
Fc (fragment crystallizable) receptor (FcRn) that binds and
mediates the transepithelial transfer of immunoglobulin G
(IgG) (5–11).
This property of the intestinal epithelium is largely lost
with the progress of development and maturation, during the
fetal and neonatal periods, until macromolecular transepithelial
transfer ceases at the time of the so-called “gut closure.” In
the mature intestine, after gut closure, some macromolecular
transfer still takes place, but the extent of transfer is limited
and it is restricted in terms of intestinal area, with transfer
occurring mainly in the follicle-associated epithelium, especially
over the membranous cells (M-cells), overlaying the immune-
cell rich regions in the small intestine known as the Peyer’s
patches (12). Recent research also suggests passage of antigenic
molecules through intestinal goblet cells (13). In addition, a
paracellular leakage of larger molecules after an inflammatory-
induced opening of the epithelial tight junctions may also
occur (14).
This review will focus on the developmental processes
taking place in the intestinal epithelium, highlighting the
high macromolecular passage during the critical perinatal
period and the impact of such passage on the development
of immunity in the young, with possible effects later in
life. In addition, the review will describe the differences
in timing and amount of such macromolecular transfer
between species, in particular those used as animal models





The extent and time period of macromolecular transfer over
the immature intestine, before gut closure, is dependent on
animal species (1). In eutherian (placental) species, this appears
to be linked to the type of placentation and number of tissue
layers separating the fetal and maternal blood circulations, hence
affecting the extent of the macromolecular transfer between
mother and offspring. In non-mammalian vertebrates, such as
fish and birds, maternal macromolecular transfer takes place
from the yolk, over the yolk sac endoderm, and finally to the
offspring’s blood circulation (1, 15, 16). In mammalian species,
such as rodents, the yolk sac is everted and participates in some
macromolecular transfer from the uterus, however, the immature
neonatal gut takes over this role and constitutes the main route
of macromolecular transmission in rats and mice (1, 4). In other
mammalian species, such as ungulates and primates, the yolk sac
either atrophies during gestation or is absent (17). In ungulates
macromolecular transfer occurs from the first milk, known as
colostrum, via the immature gut for a short period after birth,
while in primates the main macromolecular transfer is occurs
via the placenta and intestinal macromolecular transfer is largely
restricted to fetal life (Table 1).
Lagomorph and Rodent Species
In the lagomorph rabbit and in precocious rodent species,
i.e., the guinea pig, macromolecular transfer takes place from
uterine secretion via the everted yolk sac during the fetal period
(15, 29). Even though the yolk sac endoderm may endocytose
macromolecules indiscriminately, this transfer is selective since
the yolk sac endoderm expresses FcRn that binds and mediates
the transfer of IgG to the fetal circulation (18, 19). Thus, guinea
pigs are born relatively mature, equipped with their mother’s IgG
repertoire, and intestinal macromolecular transfer is negligible
postnatally (20, 22).
In altricial rodents such as rats and mice, similar to guinea
pigs, some macromolecular transfer takes place in utero during
the late fetal period, via the endocytic cells of the everted yolk
sac endoderm. However, this is quantitatively less important
compared to the postnatal intestinal transfer (9, 23), which is
selective and occurs during the entire suckling period until
weaning (24, 25).
The macromolecular uptake and transepithelial transfer takes
place with regional differences along the small intestine. In the
proximal part (jejunum), highly endocytic fetal-type enterocytes





























TABLE 1 | Overview and comparison of macromolecular transmission between mother and offspring in different species.
Taxon/species Pre- or Postnatal Gestation length Maternal source Route of transfer
to offspring















Prenatal 3–4 weeks Uterine secretion Everted yolk sac Receptor-mediated
endocytosis, FcRn/IgG

















3 weeks 2–3 weeks
Rodents
(guinea pig)
Prenatal 8–10 weeks Uterine secretion Everted yolk sac Receptor-mediated
endocytosis, FcRn/IgG











Postnatal Colostrum Proximal small
intestine
Macropinocytosis, (FcRn) 1–2 days 4–12 weeks
Carnivores
(cat, dog)




Postnatal Milk Small intestine Macropinocytosis 1–2 days 4 weeks
Primates
(human)








Summary data including, pre- and/or postnatal transfer period, gestation length, maternal source, transfer route and mechanism of transfer, i.e., selective transfer of antibodies (IgG or IgY) by receptor-mediated (FcRn or FcRY) endocytosis
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express FcRn receptors that bind and mediate the transepithelial
transfer of IgG, as well as minor quantities of other milk proteins
(24, 25, 47–49). The intestinal expression of the FcRn receptor
is consistent with the high percentage of IgG (∼80% of total
Ig) present in rodent milk in comparison with that of human
breast milk (∼10%) (50). In fact, intestinal FcRn expression in
premature rat pups is higher than that observed in term rats,
suggesting a compensatory mechanism to counteract the low IgG
passage during the fetal period (51).
In contrast, in the distal small intestine (ileum), the fetal-
type epithelium internalizes luminal material via the apical
endocytic complex and forms large digestive vacuoles that make
up most of the cytoplasmic content (26, 52), allowing little
macromolecules to pass the epithelium intact. The endocytosis
machinery in mouse ileal enterocytes was recently identified and
described as consisting of the multi-ligand scavenger (protein)
receptors, Cubulin and Amnionless, together with the adaptor
protein, Dab2, as mediators of the endocytosis mechanism (53,
54). In fact, these highly endocytic intestinal cells equipped
with this multi-ligand endocytic machinery were also found in
the zebrafish, indicating a conserved presence and function in
vertebrates. Thus, instead of mediating transepithelial transfer
of macromolecules; the cells of the rodent distal small intestine
play a nutritional role with intracellular digestion, especially of
protein, sustaining the rapid post-natal growth.
At about 2 weeks of age, when pups open their eyes and start to
become interested in nibbling solid food in addition to suckling
milk, adult-type epithelial enterocytes with drastically reduced
endocytic capacity and decreased FcRn expression appear in the
crypts and move up the villi, in both the proximal and distal parts
of the small intestine. By 3 weeks of age, at weaning (27), this
maturation process has finished and gut-closure is completed,
so all fetal-type enterocytes have been replaced by the adult-type
epithelium (49, 55–58).
Precocious intestinal maturation may be induced by
premature weaning (59) or by luminal stimulation of suckling
rats by, e.g., exposure to the lectin, phytohaemagglutinin
(PHA), binding to the mucosa (60); experimental feeding of
the polyamine, spermine (61, 62); administration of exogenous
corticosteroids (63, 64) and by provocation with proteases
(65). All these treatments stimulate crypt-cell proliferation, and
thus, increase intestinal epithelial cell turnover and renewal to
adult-type enterocytes with heavily decreased endocytic activity
and macromolecular transfer capacity along the villi.
Ungulate (Hoofed) Species
In ungulate species, the epitheliochorial placenta consists of
four epithelial/endothelial layers between the maternal and
the fetal circulations, which constitutes an impermeable and
effective barrier to macromolecules. Therefore, ungulates, i.e.,
piglets, lambs, calves and foals; are agammaglobulinemic at
birth and during the first 1–2 days of life they display
an extensive macromolecular transmission, including that of
colostral antibodies over the intestines, making suckling essential
for survival (32). The macromolecular transfer takes place by
free-fluid endocytosis (macro-pinocytosis) in the proximal part
of the small intestine and it is essentially a non-selective process.
The enterocytes in the distal small intestine are also highly
endocytic but the vesicles coalesce and form giant cell vacuoles
designated for intra-cellular digestion and little, if any, of the
macromolecules will survive intact and reach the basolateral
side (4, 33). The period of intestinal transmission in newborn
ungulates (piglets) matches the maternal (sow) production of
colostrum, which is not only rich in nutrients, but also has a
high content of IgG and other bioactive proteins. The FcRn
receptor has been identified in the intestinal epithelium in piglets
and lambs (34, 66) but it does not seem to be essential for the
transfer of IgG, since a variety of macromolecules, including
non-proteins like polyvinyl pyrrolidone (Mw 60.000) (67) and
FITC-dextrans (Mw 3.000–70.000) (35, 68), can be absorbed.
During this period, transfer of intact IgG and other colostrum
whey proteins is facilitated by the high colostral protein content,
that per se stimulates endocytosis (35), as well as the presence
of a specific colostrum protease inhibitor (SCTI), which in turn
decreases luminal protein degradation (69, 70).
At 1–2 days of life, if feeding has been initiated, gut closure
takes place and the epithelium in the proximal small intestine
loses its macromolecular transfer capacity (1, 68). The exact
mechanism is not yet known, but the luminal proteolytic activity
increases as the colostrum inhibitor level rapidly decreases, and
the intestinal epithelial cells either lose their highly endocytic
capacity or this capacity is limited and ceases after being fully
utilized. In contrast, the endocytic capacity of the epithelium
in the distal small intestine remains until up to 3 weeks
of life and endocytosis of luminal material for intracellular
vacuolar digestion continues (4, 33) until the epithelium of
the entire small intestine is exchanged to adult-type epithelium
and the endocytic capacity ceases. Thus, in ungulate species,
macromolecular closure occurs early after birth in the proximal
intestine without substantial cell replacement and unrelated to
the weaning process.
Carnivore Species
In cats and dogs some maternal IgG is transmitted over the
placental structures to the fetus, but the main macromolecular
transfer occurs postnatally from colostrum, in a similar manner
to that of ungulate species (37, 38). Characteristically, the
intestinal epithelium is heavily vacuolated, indicating extensive
endocytosis and closure of transepithelial macromolecular
transfer occurs 1–2 days after birth. After this, macromolecular
uptake and intracellular vacuolar digestion continues for some
weeks until these epithelial cells are replaced and intestinal
maturation is completed.
Primate Species
In contrast to the previously discussed mammalian
phyla, primates, i.e., humans, show profound transfer of
immunoglobulins already during the fetal period, across the
hemochorial (chorioallantoic) placenta. Due to the “simple”
human placenta being formed by one epithelial layer between
fetal and maternal circulations, it allows for maternal-fetal
macromolecular transfer. This transfer is selective and takes
place by receptor-mediated transcytosis, binding of IgG to FcRn,
across the syncytiotrophoblast cells (71). The transmission of IgG
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is low during the early fetal period (1st and 2nd trimesters) but
increases significantly during the late fetal period (3rd trimester).
Hence, premature infants are born with lower IgG levels in the
blood than full term infants.
In addition to the major placental IgG transfer, some
macromolecular passage can also take place in utero over the
intestine, since vacuolated enterocytes have been observed in the
mid-distal intestine from about 13–14 weeks of fetal life (72) and
a capacity for endocytosis has been described (40). Moreover,
FcRn receptors have been identified in the apical membrane
of intestinal epithelial cells and are able to bind IgG molecules
present in the amniotic fluid after swallowing, mediating their
endocytic transfer to the fetus (5, 8, 41). This capacity is lost at
mid-gestation since the fetal-type enterocytes are exchanged for
enterocytes lacking endocytic properties and gut closure appears
to occur already in utero in humans (4, 40). At birth, full term
neonates are equipped with an essentially adult-type intestinal
epithelium, with low expression of the FcRn receptor and thus
the endocytic capacity is largely lost. Hence, macromolecular
transfer in the newborn is low, albeit somewhat higher than
in the adult (42). The oral sugar (lactulose/mannitol) test has
indicated increased intestinal permeability for a short period of
about 1 week after birth, which can be prolonged by prematurity
or formula-feeding (43, 73–76). Since the intestinal epithelium
still expresses some FcRn receptors, it has been suggested that
luminal IgG/antigen complexes might be transported over the
intestinal barrier into the lamina propria, to interact with antigen
presenting cells and other immune cells (44, 77).
In general, different strategies for macromolecular transfer
from mother to offspring have evolved, from taking place via
the yolk sac endoderm and/or fetal intestine to occurring after
birth via the immature intestine, and lastly mainly via the
placenta in primates (4). Nonetheless, all mammalian species
undergo a period of high endocytic activity of the immature
intestinal epithelium and/or yolk sac epithelium, which are all
cells of endodermal origin, allowing for an enhanced transcellular
transfer of maternal macromolecules to her progeny. Mostly, it
is a selective transfer of IgG, shuttled and regulated by epithelial
expression of FcRn, to secure the transfer of protective maternal
immunity. However, dietary and microbial macromolecules can
also be transmitted, either as part of a complex with IgG, selected
due to the maternal antibody specificity, or in free antigenic form
by non-selective endocytosis. In all cases this period of decreased
epithelial barrier function with increased transfer of maternal
antibodies and environmental antigens will have an impact on the
activation and maturation of the submucosal immune system.
THE IMMATURE IMMUNE SYSTEM IN
FETAL/NEONATAL LIFE
The formation of the immune system in humans starts in the
embryo, develops during fetal life and only reaches maturity
some years after birth (78). However, the precise organization
and functionality of the early life, immature immune system is
still poorly understood, both at systemic and local levels.
A Species Comparison
The formation and development of the immune system
in rodents is delayed compared to humans, due to their
short gestation period (3 vs. 42 weeks, respectively) and
consequently, their relative immaturity after birth. Thus, it is
established that the lymphoid architecture forms prenatally in
humans while it occurs mainly during the postnatal period
in rodents, and for that reason newborn rodents resemble
and can be used as a model for prematurity in humans.
However, overall, in both cases, they develop with similar
schemes (79).
In rodents, and particularly in rats, development of inductor
lymphoid aggregates, as Peyer’s patches, and effector immune
cells found scattered in the epithelial layer (i.e., Intraepithelial
lymphocytes, IEL) or in the lamina propria (i.e., Lamina propria
lymphocytes, LPL), have been well characterized (28). Almost all
major IEL and LPL subsets identified in adults are already present
in suckling rats, but in different proportions. After birth, both
IELs and LPLs expand in numbers based on the generation of
precursors and their migration from the thymus to peripheral
tissues, especially increasing during the second week of life which
coincides with the contact with new antigens due to the start of
solid food ingestion or weaning, which has been proven crucial
(80, 81). Intestinal IgA production is very low during early life
and the number of IgA-secreting B-cells at the end of the suckling
period is far lower than that in adult rats (81). Many of these
immune features are even less developed when rats are born
prematurely (51, 82).
It has been proposed that T-cells are mediators of intestinal
epithelial cell differentiation and they contribute to the
maintenance of the epithelial barrier function (83). It is also
known that T-cells, in the neonatal intestine of mice, are
inhibited by T-regs and IgA-mediated antigen translocation
(84). Innate lymphocytes (ILCs) in the GI tract have been
suggested to constitute the counterpart of T-lymphocytes in
innate immunity (85), with a role as integrative factors
being both receivers and regulators of multisystem signaling
in the gut (86). Noteworthy, in the neonatal intestine, a
specific type of ILCs (type 3) has been described as the first
immune cell colonizer (87), and they have been proposed
to function as inhibitors of the immune response in early
life (88).
In ungulate pigs, the complex maternal-fetal placental
separation prevents the transfer of maternal immune
components, such as Ig or cytokines, to the fetus, thus making
intestinal passage during suckling essential for development
of the immune system. The structure of innate immunity in
pigs is similar to that of other mammals, with natural killer
cells (NK) being the key cell-type in early life, even though their
functionality is only achieved after birth when immunoregulatory
bioactive molecules appear during breastfeeding (36). Although
there is significant lymphopoietic activity in the fetal liver,
bone marrow and thymus, the adaptive immunity at birth
is comprised mostly of immature, low effector/memory
T cells and mainly un-primed B–cells. Accordingly, the
mucosal adaptive immune system in the neonatal piglet is also
immature (36).
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In human fetuses, B- and T-cells are found in the intestine as
early as between 12 and 14 weeks gestation and their abundance
and maturation increases until birth (89). It has been recently
demonstrated that both the innate and adaptive immune systems
are present as early as 16 weeks of gestation. Furthermore, fetal
leukocytes display a distinctive differential clustering compared
to neonatal intestinal tissues and have established T-cell and B-
cell receptor diversity. In addition, most effector memory cells
have a tissue resident memory (TRM) phenotype and secrete
TNF-α and IFN-γ (90). Despite this, the low levels of immune
cells observed in the intestine during early life, among them TRM
cells andNK cells, with a lower proliferative or cytotoxic response
of T cells, and dysregulated cytokine or lower IgA production,
indicates a general immaturity of the immune system, leading to
increased susceptibility to infections (91).
In early life, the immaturity of the immune system is paralleled
with the immaturity of the intestinal barrier function, resulting
in a higher passage of antigens across the intestine. Thus, within
this particular time period it is essential that a balance is reached
between avoiding infection while at the same time activating the
immune system and inducing antigen tolerance.
Immunomodulatory Breast Milk
Components
In all mammalian neonates, breast milk is the principal nutrient
source, but also the main driving factor in the maturation,
activation and expansion of immune cells, particularly at mucosal
sites. Even though 87% of breast milk content is water, the
remaining 13% contains nutrients, as well as important bioactive
compounds that have beneficial, non-nutritional functions (92).
These compounds include, in addition to IgG in some species
as discussed above, secretory IgA, antimicrobial factors like
lactoferrin and lysozyme, cytokines, growth hormones and
digestive enzymes, among others (43, 93–95). These milk-
borne bioactive compounds are involved in the acquisition and
appropriate establishment of the newborn’s intestinal microbiota
and immune system development (96). Secretory IgA (sIgA)
in particular, contributes to shaping the microbiota during the
suckling period and the breast milk oligosaccharides modulate
the infant’s microbiota by promoting the selective growth of
health beneficial bacteria, like bifidobacteria, in the intestine.
Maternal immune cells are also present in breast milk and
have been shown to be able to survive and pass the intestinal
epithelial barrier and translocate into the newborn’s tissues
(97–101). Transfer of maternal immune cells may also occur
during gestation, when maternal and fetal cells are exchanged
across the placenta (102). However, this fetal cell transfer is
quantitatively less marked than that which occurs following the
ingestion of colostrum, due to its high content of immune cells.
Furthermore, translocation of immunocompetent cells from
mother to offspring has been shown to provide offspring with
effective immunity and has been shown to have modulatory
effects on the immune response in the young, thus influencing
the development of their own immune system (103).
Breast milk contains an array of cytokines and growth
factors involved in the newborn’s immune system development,
i.e., IL-6 stimulates differentiation of IgA-producing cells; IL-
10 promotes tolerance to dietary and microbiota derived
antigens, downregulates inflammation and promotes healing of
damaged intestinal cells (104). In addition, the presence of pro-
inflammatory cytokines, such as IL-8 and TNF-α, has also been
reported in human milk. The growth factors in breast milk,
TGF-β1 and TGF-β2, promote functional development of the
gastrointestinal mucosa and are immunoregulators, whereas the
epidermal growth factor (EGF) participates in tissue repair and
growth and may contribute to the tightening of intercellular
junctions (102). The cytokine profile of breast milk changes
during the lactation period with differences in relative cytokine
content in colostrum, transition milk and mature milk and,
in addition, breast milk composition is also adapted to the
delivery period, being different in term, preterm and very preterm
neonates (104). Some of these bioactive factors, such as the EGF,
have a low intestinal absorption ratio and they function mainly in
the development of the gut and mucosal immune system, while
others such as IL-2, are mostly absorbed and by entering the
systemic circulation they can influence the maturing immune
system (105).
Recently, the microbiomes of breast milk from humans
(106), rats (50) and pigs (107) have been described. Milk
microbiota have been suggested to function in the establishment
of the infant’s gut microbiota through the initial inoculum of
the GI tract with microorganisms, and thus has been named
“mother nature’s prototypical probiotic food.” It is estimated
that infants consuming about 800mL of breast milk per day
obtain ∼105-107 bacteria from the milk (108, 109). Thus, the
maternal microbiome and maternal diet influences not only the
composition of the breast milk, but also the composition of
the infant’s microbiome (110, 111).
Effects of Microbial Colonization
The colonization and expansion of beneficial bacteria in mucosal
tissues during early life is not only important in the reduction
of enteric infections, through competition with pathogens for
the ecological niche and the production of antimicrobial agents
or improvements in intestinal barrier function (108), but also
through the stimulation and education of the host’s immune
system (109).
Among the many factors involved in the maturation of the
intestinal immune system during early life, the colonization and
establishment of a dynamic and appropriatemicrobiota is crucial.
Exposure to microbes during early childhood is associated
with protection from immune-mediated diseases later in life by
permanently impacting the function of natural killer T (NKT)
cells (112). NKT cells are a subset of cells which connect the
innate and acquired immunity essential in early life (113) and
are related to the development of allergic diseases in human
subjects and mice (114). Additionally, similar levels of receptors
that recognizes microbes and microbial components, such as the
toll-like receptors (TLRs), have been found in human neonates
and adults, although their activation causes immune reactions
that are not as strong during early life (115). In fact, dysbiosis
in infants seems to correlate with altered immune shaping and a
chronic pro-inflammatory state later in adulthood (116).
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In newborns, microbial antigens from the intestinal
environment cannot be counteracted by a typical antibacterial
and antiviral T helper type 1 (Th1) cell response, they induce
a T helper type 2 (Th2) response instead, activating T cells
and neutrophils via interleukin 8 (IL-8) (117). In contrast, an
infant’s dysbiotic microbiota would promote the Th1 response
involving the production of pro-inflammatory cytokines, such as
IL-12 and interferon (IFN)-γ (110). Regulation of the immune
response seems to involve myeloid-derived suppressor cells that
are already present in early life, which have demonstrated a
strong ability to suppress T cells in mice and humans (118).
These specific actions of the intestinal immune system limits
continuous inflammatory damage and allows for intestinal
colonization by the microbiota.
Overall, the time window for appropriate host-microbe cross-
talk and therefore immune imprinting by microbiota, mainly
takes place from birth to weaning, a period that involves a large
expansion and diversification of the intestinal microbiota (119)
and which coincides with the time window of increased antigen
passage across the intestine.
The microbial and immunomodulatory components, at both
the maternal and infant levels, are dependent on several factors
which are considered as positive or beneficial when they
promote the growth of bacterial genera, such as lactobacilli
and bifidobacteria. Factors which positively shape the neonatal
microbiome include vaginal delivery, maternal health status, long
duration of lactation and the absence of antibiotic treatment
during both pre- and post-natal periods. In contrast, factors
that cause alterations in the infant’s microbiota are C-section
delivery, maternal disease status, especially infections that
require antibiotics use; or absence of lactation that results in
formula feeding (106, 110, 120, 121). These negative factors,
such as antibiotics, not only reduce the previously mentioned
bifidobacteria and lactobacilli beneficial bacterial groups, but also
seem to affect other bacterial groups such as Proteobacteria,
Firmicutes or the Clostridium cluster XIVa (121).
The microbial colonization of the intestine after birth will
generate a diversity of new antigens that will play an important
role in stimulating epithelial function and establishing the
offspring’s immune system (122). Weaning, with the loss of milk-
born sIgA and other anti-microbial factors and the transition
frommothers’ milk to a complex diet will have a major impact on
the dynamic microbiota development and thus in the resulting
immune response during the neonatal period.
IMPACT OF INTESTINAL
MACROMOLECULAR TRANSFER IN THE
FETAL/NEONATAL PERIOD
At birth, when the offspring leaves the safety of the mother’s
womb, the intestinal barrier function is of utmost importance
due to its dual function in preventing the passage of
potentially harmful molecules and selectively allowing bioactive
molecules and antigens to pass through. The barrier function
is accomplished by several components including the luminal
content, formed by endogenous secretions; the microbiota
and the mucus layer; the intestinal epithelium itself, and the
underlying immune system. The intestinal epithelium, a single
layer of polarized cells, forms a key portion of the selective
barrier, due to the endocytic capacity of the immature intestinal
epithelium to select and shuttle those molecules which are
allowed to pass through and reach the sub-mucosa and general
circulation. Among the important macromolecules that require
selective passage are the maternal antibodies, especially IgG, as
well as the bioactive components in the amniotic fluid and breast
milk and the microbial and dietary antigens (Figure 1).
Passive Immune Protection by Maternal
Antibodies (IgG)
The transfer of antibodies from immune competent mothers,
either during fetal life or after birth, independent of route,
provides newborns with effective immune protection, especially
taking into account that they will most likely be exposed to
the same environmental pathogens. These passively acquired
maternal antibodies enter the blood circulation and provide the
same protective function as actively produced antibodies. The
benefit of acquiring the mother’s cumulative antibody repertoire
has been shown in both human and animal studies (1, 123,
124). For example, newborn husbandry ungulates, e.g., lambs
or piglets, that for some reason are not able to or are not
allowed to suckle and are thus deprived of naturally receiving the
IgG in colostrum, will rapidly weaken and will usually develop
post-natal diarrhea and succumb (125). In human neonates,
since IgG is already transferred across the placenta, difficulties
with regards to breast-feeding has less dramatic consequences.
Even children that are genetically incapable of producing IgG
(X-linked agammaglobulinemia) are protected against most
infections for a few months by maternal antibodies. However,
antibodies, like all proteins, are metabolized over time and
IgG declines to non-protective levels, rendering these children
extremely sensitive to infections (126). Previous studies in both
rodents and humans have shown that maternally acquired IgG
can also be transported back into the intestinal lumen, from
the circulation, via the FcRn receptor (44). This can exert local
protective effects, which are especially important in humans, in
instances where milk contains low levels of IgG or when infants
are fed with formula (127).
In addition to immune protection, passively acquired
maternal antibodies reduce the metabolic costs of generating an
active immune response in the offspring. Thus, passive immunity
minimizes growth-suppressive effects that may be caused by
activation of the immune system in species with rapid growth
after birth (128). However, there is also a drawback with regards
to the transfer of maternal antibodies, since it can inhibit active
immunization and cause problems concerning the efficacy of
vaccination of young infants, as described in both in human and
veterinary medicine (129).
Recent results also indicate the existence of extra-
immunological effects of maternal antibody transfer in addition
to the classical protective immune effects, including direct effects
on growth and functional development of the brain, the gut
and possibly other organ systems in the neonate (130–132). The
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FIGURE 1 | Schematic illustration of the maturational changes taking place in the small intestine, with the replacement of endocytic fetal-type epithelial cells by mature
adult-type cells lacking these features during fetal/neonatal development of young mammals. Maternal macromolecules/antigens in amniotic fluid or milk (colostrum),
as well as microbial antigens, may pass over the fetal and neonatal epithelial barrier and activate the underlying immature immune system. The transfer of maternal
IgG is facilitated by receptor-mediated endocytosis by epithelial FcRn receptors. With maturation, at gut closure, epithelial cell endocytosis ceases and the
transepithelial macromolecular passage is largely restricted. In addition to low physiological antigen passage over the adult-type epithelium, a loss of barrier integrity
due to e.g., inflammation, can increase the passage of dietary or microbial antigens and impact the immune system.
additional properties of circulating maternal Ig could have an
impact on human neonates, especially those born prematurely
with low plasma IgG levels.
Effects of Transfer of Antigenic
Macromolecules
In addition to the passive immunization by maternal transfer of
antibodies (IgG), milk cells and bioactive molecules; enhanced
macromolecular passage over the intestines during the fetal
and neonatal periods also results, although with some variation
in quantity and timing between various species, in increased
microbial and dietary antigen exposure and presentation to
the underlying immature immune system. The outcome of
antigenic exposure and the resulting immune response during
this critical time window will be dependent on the maturity of the
immune system and can either result in effector cell activation or
tolerance induction.
Gut Luminal Effects on Antigen Transfer
During the fetal and neonatal periods, intestinal luminal
digestion is generally low due to the immature stomach
and pancreatic function and the presence of milk-borne
protease inhibitors (27, 55, 133). The reduced luminal
enzymatic activity during these periods functions to keep
molecules intact until they reach the intestinal epithelium, thus
preserving antigenicity and possibly increasing the extent of
their subsequent transepithelial passage (134). Antenatally,
components in the amniotic fluid like proteinase inhibitors,
and, postnatally, bioactive components in colostrum and
milk, will influence the luminal environment and hence the
formation and stability of antigenic molecules. In addition,
milk oligosaccharides can bind to viral and bacterial antigens
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blocking their interaction with host cell-surface glycans, and
thus prevent infection or dysbiosis, as well as their translocation
into sub-mucosal sites (135). Hence, increased amounts of
accessible antigenic molecules in the lumen will add to the
enhanced intestinal macromolecular transfer, boosting the
exposure of the immune system to these macromolecules during
the perinatal period.
Forms and Routes of Antigen Transfer
The antigen format, free vs. immune-complex bound, is a
factor of importance for the immunological outcome. Thus,
transepithelial passage of antigens, bound in complex tomaternal
IgG and transported via FcRn, has been observed in both rodents
and humans, and the subsequent interaction of these immune-
complexes with lamina propria antigen presenting cells might
be facilitated by their binding to Fc-receptors on these cells
(11, 44, 77, 136–138). In fact, microbial antigens, of maternal
intestinal origin, in complex with maternal antibodies (antigen-
IgG complexes) are transferred via the placenta in primates or via
colostrum/milk and intestinal transfer in other species, and hence
induce immune activation in the offspring (139–141). Thus, the
FcRn receptor appears to be important for the protection of
antigens in complex with IgG from degradation and for guiding
the antigen through the epithelial cells during transport and
sub-epithelial exposure.
Free dietary antigens may also pass materno-fetal barriers,
since proteins experimentally fed to pregnant rats have been
detected in antigenic form in both amniotic fluid and fetal blood
(142). This may affect the immune response in neonates and shift
it causing immune activation and inflammation as usually seen
in the adult (143, 144) instead of induction of tolerance.
Experiments in neonatal rats have shown that anti-nutritional
factors, such as lectins, block intestinal absorption (145), and oral
provocation with the lectin PHA severely decreases endocytosis
immediately after exposure (146, 147), due to the binding to
the epithelial surface (146, 148, 149). Hence, PHA is thought to
have blocked epithelial “receptors” needed for endocytosis. In
contrast, provocation feeding with a protease caused an instant
decrease in receptor-mediated endocytosis, a gradual decrease in
the non-specific endocytic pathway and a temporary increase in
paracellular leakiness (147).
Changes in paracellular permeability are caused by the
disassembling of intestinal tight junctions, regulated by proteins
such as claudins, zonulin, and occludin, causing a loosened
pore diameter which in turn allows “larger” molecules to pass
through (150–154). Tight junction proteins, specifically zonulin,
have been associated with activation of the protease-activated
receptors (PAR-2) in the intestinal epithelium, which has been
linked to the development of cancer and autoimmune diseases
(152, 155). Activation of the PAR-2 receptor in the small intestine
has also been described as a trigger for pro-inflammatory
responses such as immune cell recruitment, mucus secretion, and
signaling to enterocytes, immune cells and the enteric nervous
system (156–159).
In general, it would seem that the pathway of antigen transfer
across the intestinal epithelial barrier could affect the immune
system response. Transcellular passage of antigen complexes act
as an educational pathway for the newborn’s developing immune
system, whereas paracellular passage would cause a primary
immune response against those free antigens. Hence, during this
critical period of early life, there is a continuous balance between
tolerance induction and effector immune responses (13).
Effects of Antigen Transfer on the Immune
System
The communication between the luminal content, including
microorganisms and dietary macromolecules, and the immune
system has been studied mostly with regards to their interaction
via the intestinal epithelial cells and their receptors, while
less emphasis has been placed on the direct interaction of
antigenic molecules after passage across the intestinal epithelium.
Moreover, the route for transepithelial passage of antigens, either
by the transcellular endocytic pathway (160) or by paracellular
“leakage” between the epithelial cells, might also be of importance
for the resulting immune response (13). After epithelial passage
of luminal antigens and interaction with the local immune system
this might either result in tolerance induction or priming of a
protective immune response, but could also result in immune
activation and inflammation.
Early studies on tissue transplantation suggest that the
fetal/neonatal immune system is immature and predisposed
to induction of tolerance (161). Transfer of macromolecules
or intact antigens across the intestinal epithelium induces
differentiation of regulatory T-cells (Tregs) and tolerance, and
further protection from allergic diseases. Recently, Ohsaki et al.,
showed that maternal cutaneous sensitization to an antigen
could prevent against antigen-specific IgE production, intestinal
mast cell expansion and food allergy in the offspring (162).
The observed effects were mediated by neonatal FcRn–mediated
transfer of maternal IgG or antigen-IgG immune complexes via
breast milk. FcRn-dependent antigen presentation to CD11c+
dendritic cells was also required to induce oral tolerance in the
offspring (163).
Dietary macromolecules that induce Treg cells at weaning
appear to be required to suppress the immune response to
dietary antigens that are important in controlling inflammatory
or allergic responses (144). Moreover, maternal IgG against
maternal gut microbiota, that are transferred after birth in mice
and possible via the placenta in humans, limits the activation of
both mucosal T-cells and B-cells against the gut microbiota in her
young offspring (164).
Natural weaning has been classified as “physiological
inflammation,” with the recruitment of immune cells to the
gut, mediated by chemokines and cytokines released by the
enterocytes (165). T-cell recruitment to the neonatal mucosa
has proven crucial for gut maturation and immune system
activation, as well as for the establishment of oral tolerance in
early life (80, 166–171). The prominent changes in microbiota
induced by weaning seem to be required for immune maturation
and the induction of Treg cells, while disturbances in the
weaning reaction lead to pathological conditions, with increased
susceptibility to allergy and inflammation later in life (172).
As discussed above the route of transepithelial passage
of antigens is important in determining the immune
response/outcome, where transcellular passage with enterocyte
processing and FcRn biding may be preferable compared to
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paracellular passage (leakage), which instead might result in
inflammation and/or sensitization. The high endocytic activity of
fetal-type enterocytes and increased macromolecular intestinal
permeability might contribute to the increased susceptibility of
preterm and term neonates to enteric infection and allergies.
The immaturity of the intestine, together with the high epithelial
endocytic activity, is possibly involved in the high risk of
developing necrotizing enterocolitis (NEC) in preterm infants
(173, 174).
PERSPECTIVES AND CONCLUSIONS
Selecting an appropriate animal species to serve as an ideal
model to study the gut and immune system of human infants
is not an easy task. The neonatal suckling rat (28, 82) and the
newborn pig (175, 176) have often been used for this purpose.
The rat is an altricial species, born very immature and with
a permeable intestine during the entire suckling period, which
is quite different from human infants. The suckling rat should
probably rather be used as a model for premature infants. The
newborn piglet on the other hand, is born agammaglobulinemic
with a highly permeable intestine during the first day of life,
which is essential in the acquisition of passive immunity.
However, this also differs from that which occurs in newborn
human infants. Instead, newborn guinea pigs (21) or rabbit
pups, which are precocious species, born with their mothers’
immunity and a relative mature gut, exhibiting low intestinal
permeability, might be more suitable models for newborn
humans. However, the latter species are often considered as
less favorable from an experimental, practical and economic
perspective, since among other things, the rat and the pig are
multiparous species that normally give birth to between 10 and
20 or more offspring. Nevertheless, it is of utmost importance
to keep in mind the particularities of each species, and to
adapt each model species to the human model, such as the
relevance of using piglets before or after ingestion of colostrum,
as well as the gestational time in the case of using premature
animal models.
This review contributes to a better understanding of how
macromolecules of dietary and microbial origin in the intestinal
lumen are delivered to the underlying immune system and
how this transfer changes during development in perinatal life.
Any disturbances in the timing and/or balance of these parallel
processes, i.e., intestinal maturation, gut immune maturation
and luminal microbial colonization, e.g., due to preterm birth,
perinatal infection, antibiotic use or nutrient changes during
the neonatal period, might affect the establishment of the
immune system in the infant. Understanding the development
of intestinal macromolecular permeability, in different animal
models, will increase our understanding of intestinal barrier
function and provide strategies for the prevention of infection
and inappropriate antigen transport affecting the immune
response. This might also contribute to a better understanding of
the etiology of inflammatory diseases of the gastrointestinal tract
and in potential preventive and therapeutic strategies.
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